Chemotherapy Induced Thrombocytopenia clinical trials

Explore recruiting chemotherapy induced thrombocytopenia clinical trials.

Recruiting chemotherapy induced thrombocytopenia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chemotherapy Induced Thrombocytopenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Multi-Center, Double-Blind, Phase III Study Evaluating the Efficacy and Safety of Hetrombopag Olamine Tablets vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia

France, Romania, Poland, Spain, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer (RECITE)

Spain, Portugal, France, Italy, Romania, Greece +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Greece, Portugal, Romania, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chemotherapy Induced Thrombocytopenia trials by city

Chemotherapy Induced Thrombocytopenia in Toronto Chemotherapy Induced Thrombocytopenia in Vancouver Chemotherapy Induced Thrombocytopenia in Montreal Chemotherapy Induced Thrombocytopenia in Calgary Chemotherapy Induced Thrombocytopenia in Edmonton Chemotherapy Induced Thrombocytopenia in Ottawa Chemotherapy Induced Thrombocytopenia in Winnipeg Chemotherapy Induced Thrombocytopenia in Quebec City Chemotherapy Induced Thrombocytopenia in Hamilton Chemotherapy Induced Thrombocytopenia in Kitchener Chemotherapy Induced Thrombocytopenia in London Chemotherapy Induced Thrombocytopenia in Halifax Chemotherapy Induced Thrombocytopenia in New York Chemotherapy Induced Thrombocytopenia in Los Angeles Chemotherapy Induced Thrombocytopenia in Chicago Chemotherapy Induced Thrombocytopenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease